Due to patent disputes.

Apple's decision comes after the U.S. International Trade Commission (ITC) ruled in October that Apple infringed on patents held by medical technology company Masimo. Masimo is known for its non-invasive medical monitoring devices, particularly its pulse oximeter.

According to Reuters, US users will no longer be able to order these two products from the Apple Store online starting at 3 PM on December 21st, while Apple retail stores will continue to ship the devices until December 24th. However, customers in other countries can still purchase them as usual.

The dispute between Apple and Masimo has been protracted and escalating over the past few years. Masimo has filed two separate lawsuits, one in the District Court for the Central District of California and one with the ITC. The company alleges that Apple stole its SpO2 measurement technology to incorporate into the Apple Watch.

The dispute resulted in an import ban by the ITC. Apple representatives objected to the decision and stated that the company would appeal to the Federal Court. However, Apple subsequently decided to comply by ceasing sales of the product from December 25th.

An Apple spokesperson affirmed that the company would "examine all possible measures to deliver products to customers in the U.S. as soon as possible." This poses significant challenges for the company in maintaining relationships with American customers and managing the economic consequences.

According to Apple's report, the wearables, consumer electronics, and accessories segment, including the Apple Watch, AirPods, and other products, generated $8.28 billion in revenue in the third quarter. This decision could significantly impact Apple's business prospects in the future.

Source: https://www.congluan.vn/apple-watch-series-9-va-ultra-2-ngung-phan-phoi-tai-my-do-tranh-chap-bang-sang-che-post277138.html